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Aim To test the psychometric properties of the Croatian 
version of the Chronic Venous Insufficiency Quality of Life 
(CIVIQ) Questionnaire and to assess the quality of life in pa-
tients with chronic venous disorders of all stages.
Methods This cross-sectional study performed between 
2014 and 2015 in a private family practice assessed the fac-
torial validity, cross-sectional validity, and reliability of the 
Croatian CIVIQ 20-item questionnaire completed by 428 
adult patients (78% women) with chronic venous disorders 
classified according to the Clinical-Etiologic-Anatomic-
Pathophysiologic (CEAP) C classification as stages C1-C6.
Results Median patient age was 52 years (5th-95th per-
centile, 30-77). The distribution according to the clini-
cal stages of chronic venous disorders was as follows: C1 
(n = 78, 18%), C2 (n = 192, 45%), C3 (n = 53, 12%), C4 (n = 44, 
10%), C5 (n = 13, 3%), and C6 (n = 48, 11%). The CIVIQ-20 
factorial structure was unstable, and six items were exclud-
ed from the analysis to test the psychometric properties 
of the shortened version (CIVIQ-14). CIVIQ-14 has three 
dimensions (physical, psychological, and pain). Internal 
consistency reliability is high for the entire CIVIQ-14 (Cron-
bach α = 0.92) and for all CIVIQ-14 dimensions (α≥0.80). 
The median quality of life significantly decreased with 
higher CEAP C stages as follows: C1/C2 (86, 50-100); C3/
C4 (75, 36-98); C5/C6 (67, 31-95) (P < 0.001). Post-hoc analy-
sis showed a higher quality of life in C1/C2 than in other 
groups (P < 0.001).
Conclusion The shortened CIVIQ-14 version is useful for 
assessing the quality of life in patients with chronic ve-
nous disorders in everyday clinical practice. To achieve a 
stable validated instrument, we recommend a cross-cul-
tural validation of items that have loadings on more than 
one factor.
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Chronic venous disorders (CVDs) develop through a cascade 
of events that lead to pathological changes in the venous 
walls and/or valves and eventually to vein hypertension (1). 
The most common early symptoms include leg pain, heavi-
ness, tiredness, stinging, itching, cramps, restlessness, and 
swelling (2). The CVDs are classified in the 2004 revision of 
the American Venous Forum Clinical-Etiologic-Anatomic-
Pathophysiologic (CEAP) classification system according to 
clinical signs and symptoms, etiology, anatomical classifica-
tion, and pathophysiology. The clinical classification includes 
seven coded stages, C0 to C6. Specifically, C0 means that 
there are no visible or palpable signs of venous disease, C1 
denotes telangiectasias or reticular veins, C2 varicose veins, 
C3 edema, C4 skin changes (C4a- hyperpigmentation or ec-
zema and C4b-lipodermatosclerosis or atrophie blanche), 
C5 healed venous ulcer, and C6 active venous leg ulcer (3).
The worldwide prevalence of CVDs in the adult population 
as assessed by the Vein Consult program is 81%, ie, 20% for 
stage C0s and 61% for stages C1-C6 (C1 21.6%, C2 16%, C3 
14.6%, C4 7.1%, C5 1.4%, and C6 0.5%) (4). With such a high 
prevalence, CVDs greatly burden the society and affect the 
quality of life (QoL) of patients and their families (5). Data 
on CVDs prevalence are lacking for the population of Cro-
atia, because all venous diseases are reported under the 
overarching International Classification code ICD I80-I89 – 
Diseases of veins, lymphatic vessels, and lymph nodes, not 
elsewhere classified.
Current research indicates that higher CVDs stages are as-
sociated with lower QoL and that treatment significantly 
improves QoL (2,6,7). In addition, QoL is lower in patients 
who are elderly, overweight, or had previous superficial or 
deep vein thrombosis (7). In patients with venous leg ul-
cers, the disease affects all aspects of life from physical and 
psychological to social (8). QoL is usually measured with 
general or disease-specific questionnaires. The most com-
mon general questionnaires are the 36-Item Short Form 
Health Survey (SF-36), the 12-Item Short Form (SF-12) – 
both part of the Medical Outcomes Study – and the Euro-
QoL five dimensions questionnaire (EQ-5D) (9). One of the 
most common disease-specific questionnaires for CVDs 
is the Chronic Venous Insufficiency Questionnaire (CIVIQ), 
whose original French version consists of 20 items (10). 
CIVIQ-20 has been translated into a number of languages 
(mostly by forward-backward translation) and psychomet-
rically validated (11-14). The Croatian version of CIVIQ-20 is 
a forward-backward translation that has not been validat-
ed psychometrically in terms of reliability and factorial and 
cross-sectional validity. Furthermore, it has not yet been 
used to assess QoL in patients with healed venous ulcers 
(C5) and active venous leg ulcers (C6).
The aim of this study was to validate the Croatian version 
of CIVIQ-20 by determining its psychometric dimensions 
and, at the same time, to determine QoL in patients with 
all CVDs stages.
PATIENTS AND METHOD
Patients
Patients with CVDs were recruited in a private family practice 
between 15 September 2014 and 15 September 2016.
Chronic venous disorder was diagnosed based on the re-
ported symptoms and clinical examination findings and 
classified according to the CEAP stages C1 to C6. All pa-
tient data, including age, sex, and body mass index (BMI) 
were entered into electronic health record. BMI was de-
fined as follows: 20-24.99 – normal; 25-29.99 – overweight, 
30-34.99 – obese, and >35 – severely obese.
Questionnaire
The original CIVIQ-20 version has 20 items and four di-
mensions including pain (4 items), physical dimension (4 
items), psychological dimension (9 items), and social di-
mension (3 items), all scored on the Likert scale from 1 (no 
symptom, sensation or trouble) to 5 (highest intensity or 
frequency, depending on the item). For each completed 
questionnaire, we calculated the Global Index Score (GIS) 
following the instructions available at the official CIVIQ 
web page (14,15). All scores were calculated as ([Final 
score – minimal possible score]/[Theoretical maximal – 
minimal score]) × 100. The GIS CIVIQ-20 was calculated as 
([Final score – 20]/80) × 100. The minimal score for CIVIQ 20 
was 20, maximum 100. The GIS CIVIQ-14: ([Final score – 14] 
/ 56) × 100. The minimum score for CIVIQ-14 was 14, and 
maximum 70. For each dimension or factor, the score was 
calculated accordingly, depending of the number of items 
and minimum and maximum scores.
The patients were asked to answer the questionnaire at the 
first visit.
Statistical analysis
Categorical variables were summarized as absolute 
and relative frequencies. Continuous variables were 
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summarized as median and 5th-95th percentile. Kolmog-
orov-Smirnov test was used to test distribution normality. 
Correlation between variables was calculated with Spear-
man’s correlation coefficient.
Factorial validity of the Croatian CIVIQ-20 version was 
evaluated with exploratory factor analysis (EFA), but be-
fore factorial analysis we ran the Kaiser-Meyer-Olkin (KMO) 
measure of sampling adequacy and the Bartlett’s test of 
sphericity to test the suitability of the item correlation ma-
trix for factoring. In EFA, we used principal axis factoring 
(PAF) as the factor extraction method and Promax as the 
rotation method. We included the extracted factors with 
the eigenvalue >1, which accounted for more >10% of the 
variance, and which passed visual inspection on the scree 
plot. The factor analysis procedure use the pattern of cor-
relation between questionnaire items, which represent di-
rectly measured manifest variables, grouping them by the 
variance they share which is captured by factors that are 
interpreted as latent dimensions, inferred constructs that 
are not directly measured. Consequently, each extracted 
factor or dimension is defined only by questionnaire items 
to which it relates (16).
To assess the cross-sectional validity we used nonparamet-
ric statistics, because score distributions were not normal. 
For the GIS and the scores for three dimensions (15), we 
used the Kruskal-Wallis test to test for the differences be-
tween patient groups according to the CEAP classification. 
For post-hoc comparisons we used the Mann-Whitney U 
test. Cronbach’s alpha was used as a measure of internal 
consistency reliability. P < 0.05 was considered significant. 
The data were analyzed with the SPSS 16.0 (SPSS Inc., Chi-
cago, IL, USA) and MedCalc statistical software, version 
11.2.0.0 (MedCalc Inc., Mariakerke, Belgium).
RESULTS
Patient characteristics
Of 428 patients, 332 (78%) were women. The median age 
of all patients was 52 years (range 19-93). More than a third 
(n = 149, 35%) had a normal BMI, 190 (44%) were over-
weight, and 89 (21%) were obese or severely obese.
In 192 (45%) patients, the disorder was classified as C2, in 
78 (18%) as C1, in 53 (12%) as C3, in 44 (10%) as C4, in 13 
TABLE 1. Structure matrices (correlations of each item with the extracted dimensions) of the Chronic Venous Insufficiency Quality of 
Life Questionnaire (CIVIQ-20) factor analysis
CIVIQ-20 dimensions (factor loadings)
1st EFA* 2nd EFA*
CIVIQ-20 item physical psychological pain social physical psychological pain
 1. Leg pain 0.39 0.14 0.79 0.07 0.39 0.13 0.75
 2. Work or daily activities impairment 0.46 0.26 0.76 0.14 0.46 0.26 0.75
 3. Slept badly 0.34 0.21 0.72 0.15 0.34 0.22 0.72
 4. Standing for a long time 0.51 0.24 0.57 0.31 0.52 0.26 0.62
 5. Climbing several floors 0.82 0.24 0.37 0.09 0.82 0.23 0.36
 6. Crouching/kneeling down 0.78 0.25 0.36 0.03 0.78 0.23 0.34
 7. Walking at brisk pace 0.77 0.26 0.40 0.10 0.77 0.25 0.39
 8. Traveling by car 0.38 0.28 0.40 0.35 0.40 0.32 0.45
9. Performing household tasks 0.55 0.30 0.50 0.41 0.56 0.34 0.56
10. Going out for the evening, wedding party, cocktail 0.60 0.28 0.37 0.41 0.61 0.32 0.44
11. Playing a sport, exerting physically 0.71 0.29 0.36 0.32 0.71 0.32 0.41
12. Feeling nervous/tense 0.40 0.49 0.57 0.08 0.40 0.48 0.55
13. Feeling tired quickly 0.61 0.43 0.42 0.20 0.62 0.44 0.43
14. Feeling of being a burden 0.38 0.56 0.27 0.07 0.39 0.56 0.25
15. Being cautious all the time 0.51 0.41 0.37 -0.04 0.50 0.39 0.33
16. Feeling embarrassed about showing own legs 0.07 0.44 0.16 0.27 0.10 0.47 0.20
17. Being irritated easily 0.33 0.66 0.31 0.16 0.34 0.67 0.32
18. Feeling handicapped 0.31 0.64 0.22 0.16 0.32 0.66 0.23
19. Finding hard to get going in the morning 0.37 0.67 0.32 0.06 0.38 0.66 0.30
20. Having no desire to go out 0.37 0.71 0.12 -0.06 0.37 0.68 0.08
*EFA – exploratory factor analysis.
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(3%) as C5, and in 48 (11%) as C6. The CVDs stages signifi-
cantly correlated with BMI (rs = 0.54, P < 0.001).
Acceptability
The floor and ceiling effects were assessed to evaluate 
score distribution of the individual items. The items 14, 
18, and 20 demonstrated a substantial ceiling effect with 
more than 70% of the respondents having the lowest 
score: item 14 (n = 346, 80%), item 18 (n = 324, 75%), and 
item 20 (n = 336, 78%). No floor effects were observed.
Construct validity
Factorial validity
The KMO value (0.97) and the Bartlett’s test of sphericity 
(P < 0.001) indicated that factor analysis is appropriate for 
these data.
Principal Axis Factoring (PAF) analysis yielded a four-factor 
model. The eigenvalues of the four extracted factors were 
10.11 for the physical dimension, 1.60 for the psychologi-
cal dimension, 1.05 for pain, and 0.83 for the social dimen-
sion. These four factors accounted for 60% of the common 
variance. The structure matrix (correlations of each item 
with the extracted dimensions) and the obtained factorial 
structure (1st EFA) was complex rather than simple (Table 
1). Eight items including items 2, 4, 7, 9, 10, 12, 13, and 15 
had high loadings (>0.40), ie, correlations with factor, on 
more than one extracted factor.
The first factor, which can be interpreted as the physical 
dimension, highly correlated (>0.50) with all four items – 
items 5, 6, 7, and 9 – from the original French CIVIQ-20. 
However, four other items, specifically item 10 – “going 
out for the evening, weddings, party, cocktail”, item 11 – 
“playing a sport, exerting physically”, item 13 – “feeling tired 
quickly”, and item 15 – “being cautious all the time” had the 
highest correlations with the physical dimension. Items 10 
and 11 were originally intended to measure the social di-
mension and items 13 and 15 the psychological dimen-
sion.
The second extracted factor was the psychological dimen-
sion, with the highest loadings for six of the nine origi-
nal French CIVIQ-20 items, ie, items 12-19 and 20. Item 12 
(“feeling nervous/tense”), showed the highest loading on 
the pain dimension and items 13 (“feeling tired quickly”) 
and 15 (“being cautious all the time”) had the highest load-
ings on the physical dimension.
The third factor, pain (original items 1, 2, 3, and 4 in the 
French CIVIQ-20), had all four items from the original defi-
nition and two additional items: item 8 (“travelling by car”), 
originally intended to measure the social dimension, and 
item 12 (“feeling nervous/tense”), originally intended to 
measure the psychological dimension.
The fourth extracted factor was originally meant to be a so-
cial dimension, which included items 8, 9, and 10. The cor-
relations between the factor and the items did not exceed 
TABLE 2. Structure matrix (correlations of each item with the extracted dimensions) of the factor analysis of the Chronic Venous Insuf-
ficiency Quality of Life Questionnaire (CIVIQ-14)
CIVIQ-14 dimensions (factor loadings)
CIVIQ-14 item physical psychological pain
 1. Leg pain 0.40 0.13 0.78
 2. Work or daily activities impairment 0.48 0.26 0.75
 3. Slept badly 0.36 0.21 0.73
 4. Climbing several floors 0.83 0.23 0.35
 5. Crouching/kneeling down 0.78 0.23 0.35
 6. Walking at brisk pace 0.79 0.23 0.40
 7. Going out for the evening, wedding party, cocktail 0.60 0.32 0.41
 8. Playing a sport, exerting physically 0.73 0.33 0.39
 9. Feeling nervous/tense 0.40 0.48 0.56
10. Feeling of being a burden 0.39 0.55 0.26
11. Feeling embarrassed about showing own legs 0.10 0.49 0.18
12. Being irritated easily 0.35 0.66 0.32
13. Feeling handicapped 0.33 0.70 0.22
14. Having no desire to go out 0.38 0.64 0.11
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0.41, and none of the items had a higher correlation with 
the fourth factor than with other factors.
Because of the complex factorial structure, lack in ex-
tracting an interpretable fourth factor, the criterion of the 
eigenvalue higher than 1 (to consider extracted factor sig-
nificant), visual inspection of the scree plot, and similarity 
between our findings and the EFA results of the translated 
versions of CIVIQ-20, we performed the second explana-
tory factor analysis.
This second EFA was a PAF analysis with Promax rotation 
and a three-factor model (Table 1). The first, second, and 
the third factor can be interpreted as physical, psychologi-
cal, and pain dimensions, respectively. These factors ex-
plained 58% of the common item variance. Most of the 
items showed a correlation pattern with these three fac-
tors, which was similar to the original French CIVIQ-20. 
However, the factors were still mixed and some of the 
items showed complexity.
In an attempt to achieve a stable structure of the Croatian 
version of CIVIQ-20, we then eliminated six items includ-
ing items 4, 8, 9, 13, 15, and 19 from the questionnaire, 
as Launois et al (17) did for the French CIVIQ-14 version, 
and then factorized the Croatian version of CIVIQ-14 and 
ran PAF with Promax rotation using the three-factor mod-
el (Table 2). KMO (0.93) and the Bartlett’s test of spheric-
TABLE 3. Chronic Venous Insufficiency Quality of Life Questionnaire (CIVIQ-14) scores according to the Clinical-Etiologic-Anatomic-
Pathophysiologic (CEAP) C classification*
CEAP C (median, 5th-95th percentile)
CIVIQ-14 C1 and C2 C3 and C4 C5 and C6 P
No. (%) of patients 270 (63.0) 97 (23.0) 61 (14.0)
Global index score  86 (50-100)* 75 (36-98) 67 (31-95) <0.001
Pain  75 (33-100)* 67 (16-100) 58 (0-92) <0.001
Physical dimension  87 (37-100)* 69 (25-100) 63 (25-100) <0.001
Psychological dimension  87 (54-100)* 83 (33-100) 83 (46-96) <0.001
*Statistically different from the other two groups at P < 0.001.
TABLE 4. Correlation of Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP C) classification and its dimensions, body mass index 
(BMI), and quality of life according to global index score (GIS)
CEAP C BMI GIS Pain Physical dimension Psychological dimension
CEAP C
rs* -  0.54  -0.33  -0.27  -0.33  -0.21
P <0.001 <0.001 <0.001 <0.001 <0.001
n  428 428 428 428 428
BMI
rs - -  -0.24  -0.18  -0.30 -0.11
P <0.001 <0.001 <0.001  0.002
n 428 428 428 428
GIS
rs - - -   0.81   0.89   0.81
P <0.001 <0.001 <0.001
n 428 428 428
Pain
rs - - - -   0.68   0.55
P <0.001 <0.001
n 428 428
Physical dimension
rs - - - - -   0.60
P <0.001
n 428
*rs – Spearman coefficient of correlation.
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ity (P < 0.001) confirmed the adequacy of the correlation 
matrix for factor analysis. The eigenvalues of the three ex-
tracted factors were 7.04 (physical dimension), 1.45 (psy-
chological dimension), and 1.01 (pain). These three factors 
accounted for 59% of the common variance.
Cross-sectional validity
Cross-sectional clinical validity of CIVIQ-14 was verified by 
testing the assumption that patients with higher CVDs 
stage would report lower QoL than patients with lower 
stage and that patients with higher BMI will have low-
er QoL. To test the group differences, we merged patient 
groups C1 and C2, C3 and C4, and C5 and C6 to obtain 
comparable group sizes and a more even distribution of 
patients per group.
Our findings confirmed the assumption that QoL de-
creased with increase in CVDs stage (χ2 = 43.76, P < 0.001; 
Table 3). GIS score and scores in all three dimensions in the 
C1 and C2 group were significantly higher than scores in 
other two groups (P < 0.001).
Also, the CVDs stage (CEAP C) and BMI negatively correlat-
ed with the QoL (GIS) and its dimensions (Table 4).
Reliability
Internal consistency
Cronbach’s alpha of the overall CIVIQ-20 was 0.94 and of 
CIVIQ-14 0.92. The reliability coefficients of the CIVIQ-14 di-
mensions were lower than those of the global scales. Cron-
bach’s α was 0.86 for the pain dimension (items 1 to 3), 0.86 
for the physical dimension (items 4 to 8), and 0.80 for the 
psychological dimension (items 9 to 14).
The mean inter-item correlation for the entire CIVIQ-14 was 
0.45, and for the psychological, physical, and pain dimen-
sions 0.45, 0.66, and 0.67, respectively.
DISCUSSION
Our validation procedure of the Croatian version of CIVIQ-
20 corresponds to the procedures and results from other 
countries. The pattern of correlations between the first 
three extracted factors and the questionnaire items in 
our study is similar to that reported by Launois et al (10) 
with the original French CIVIQ-20 and in the Polish, Czech, 
and Spanish versions (17). In all these versions, including 
the Croatian, the factor intended to measure the social 
dimension was lost in validation, probably due to a poor 
construction of the dimension in the initial design of the 
questionnaire, as it had only three items (16). It seems that, 
against the initial assumption, the social dimension could 
not apply to patients with CVDs stages C1 to C4, as they 
were unlikely to report difficulties in social functioning, un-
like higher-stage patients (C5 and C6).
Because of this structural instability of CIVIQ-20 and con-
sequent inapplicability of total scores across dimensions, 
Launois et al (17) removed six items that contributed the 
most to structural instability and obtained a more stable 
version of the questionnaire known as CIVIQ-14. We re-
peated the procedure with the Croatian CIVIQ-20 version 
and the remaining 14 items had pattern nearly identical 
to the original CIVIQ-14, except for the instability in item 
9 (“feeling nervous/tense”). The item was unstable in oth-
er validations as well. For example, in a recent validation 
study of CIVIQ-14 in 17 countries, the same item (“feeling 
nervous/tense”) had loadings on the psychological and 
pain dimensions (18). The instability of item 9 lies in its 
construct, because it measures not only a psychological 
symptom (feeling nervous), but also a physical one (feel-
ing tense). Also, because pain is the consequence of ten-
sion, the item has significant loadings on all three factors. 
We suggest that the word “tense” (“napeto” in Croatian) 
should be left out in future versions of CIVIQ-14 in order 
to obtain a more stable factorial structure and limit the use 
to the psychological dimension alone. Apart from item 9, 
two more items (items 6 and 7) in our validation had load-
ings on more than one factor. Similar results were found in 
the Czech validation of CIVIQ-14, where item 7 (“going out 
for the evening, parties...”) had loadings on pain and physi-
cal dimensions (18). The validation study in Serbia also re-
vealed three items with loadings on both physical dimen-
sion and pain (13). Therefore, we believe that cross-cultural 
adaptation would be welcome in the Croatian version, es-
pecially for the items where pain and physical dimension 
are combined, such as items 6 and 7, as they have loadings 
on both factors.
Our findings confirmed that CIVIQ-14 is a reliable instru-
ment with very high internal consistency of the whole 
scale (Cronbach’s α = 0.92) and of its three dimensions 
(pain, physical, and psychological dimension; Cronbach’s 
α≥0.80). Similar results were reported in other validation 
studies (11-14).
Our results also confirmed that patients with higher clini-
cal stages of CVDs report lower overall QoL and lower 
scores for all three dimensions. This suggests that 
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CIVIQ-14 and its dimensions are reliable clinical indicators 
that may help in everyday practice. Again, similar results 
were reported in the Serbian validation study (13), where 
the measured QoL in their patients was lower than in our 
study in regard to the CVDs stage. This may point to factors 
other than those measured by either CIVIQ-14 or CIVIQ-20, 
such as gross national product, poverty, and related issues, 
such as poor health care or patient self-care.
The patients in our study had the lowest scores on the 
pain dimension. These results suggest that pain, as part 
of CVDs, is related mostly to the general perception of 
the quality of life. We believe that the experience of pain 
was far more salient in comparison to the physical and 
psychological problems captured by other two dimen-
sions of CIVIQ-14. Therefore, pain was probably the main 
reason why patients sought medical consultation. While 
pain and physical dimension scores rose from one CVDs 
stage to the next for about 6-8 points, the psychologi-
cal dimension reached plateaus at stages C3/C4. It seems 
that patients with the CVD stages C5/C6 adapted to the 
disease over time.
Our study included patients with C6 stage. Until now, C6-
patients have not been included in the international vali-
dation (11), save for Serbia (13) and Turkey (19).
The correlation of CVDs stage with the overall QoL was 
negative, as it was with all three dimensions. The correla-
tion was negative between BMI and overall QoL and posi-
tive between BMI and CVD stage. This was expected due 
to reports of a significantly higher risk of severe CVDs in 
overweight patients (7).
We did not compare the CIVIQ questionnaire with other 
general or specific QoL measures, as it was done many 
times earlier. However, our findings are somewhat limited 
because we did not follow-up our patients and retest the 
reliability of the questionnaire. This we plan to do in a fu-
ture study.
In conclusion, the CIVIQ-14 questionnaire is a simple, brief, 
and effective tool for measuring the QoL in family practice 
patients with CVDs, which may complement clinical diag-
nosis. It is a valid and reliable measurement instrument, 
which takes five to ten minutes to complete during a visit, 
and can provide helpful information in everyday practice. 
It not only provides information about the affected pop-
ulation, but also about each patient, which allows for an 
individual approach to treatment.
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